Antipyretic TRIZ Cases

A myrrh and ginger extract blend relieves pain through non-NSAID pathways, helping avoid gastric irritation and ulcers.

A tetravalent BCMA-CD3 bispecific antibody improves stability and half-life while reducing nonspecific cell killing and cytokine release.

Engineered TL1A-binding proteins use specific CDR and Fc modifications to modulate TL1A signaling while reducing side effects in inflammatory disease.

Selective tetrahydrocyclopentaindene HIF-2α inhibitors block hypoxia-driven disease pathways while limiting HIF-1α-related toxicity.

Unmodified allogeneic iNKT cells help rebalance ARDS immune response, reduce inflammation, and prevent secondary infections.

Blocking the upstream OX40/OX40L pathway helps treat canine atopic dermatitis with broader efficacy and longer-lasting relief.

Selective filtration isolates rare cells with low loss and bias, preserving them for cytomorphology, immunolabeling, and molecular analysis.

Daily Bifidobacterium adolescentis supplementation lowers CRP and TNF-α in elderly adults while supporting a healthy gut microbial community.

Phospholipid and oil-based ropivacaine formulation enables controlled release, steadier plasma levels, longer analgesia, and lower neurotoxicity.

Isolated CBD combined with balanced omega-3/omega-6 fatty acids and sterols improves formulation consistency for skin inflammation support.

A selective GPR39 agonist composition promotes intestinal cell proliferation and tight junction formation to alleviate inflammatory bowel disease.

A 3D hydrogel and PAI culture sequence activates the uPAR-plasmin pathway to isolate high-yield tissue-resident stem cells with minimal damage.

A cyclodextrin-based carrier complex improves skin delivery of antioxidants for wound healing while avoiding irritation from harsh penetration enhancers.

Four Bifidobacterium strains are combined to preserve gastric and bile resistance while improving anti-inflammatory activity and production viability.

Targeting CD30L with antibodies blocks CD30 signaling to reduce inflammatory cytokines in Crohn's disease and ulcerative colitis.

A non-opioid pain therapy uses SRP-001 to generate AM404 in the PAG, relieving pain without NAPQI formation or liver toxicity.

Learn how IFN-γ-responsive connective tissue cells induce IDO to localize immunosuppression while preserving systemic immune defense.

Sodium bicarbonate adjusts extraction pH, strengthening intestinal-function effects without requiring longer hot-water processing.

A diclofenac aqueous preparation combines isostearic acid and tertiary alkanolamine to improve skin absorption while maintaining formulation stability.

Mild hydrolysis of salmonid off-cuts yields oil constituents that reduce eosinophil function in steroid-resistant respiratory conditions.

Cromolyn stabilizes mast cells and modulates immune signaling to reduce pro-inflammatory cytokines and severe coronavirus inflammation.

Enriched M2 macrophages in a pharmaceutical composition accumulate at inflammation sites, providing anti-inflammatory action without lung trapping.

Specific CDR-engineered antibodies and fragments block TL1A activation of TNFRSF25 without the inflammatory agonism seen with earlier antibodies.

These antibodies block the CLEC2D-CD161 interaction to counter immune escape while modulating NK cell function and T cell activity.

Direct coupling replaces the complex O-to-C-prenyl rearrangement, reducing synthesis steps and supporting diverse hydroxystilbene derivatives.